 U.S. News & World Report | Bristol-Myers Insider Arrest Followed Probe of Deal Bloomberg U.S. regulators were so suspicious of the circumstances surrounding Gilead Sciences Inc. (GILD)'s Nov. 21 announcement it was buying Pharmasset Inc. for $11 billion that they opened an insider-trading investigation that day. รข€œThe volume was huge and ... Bristol-Myers to Suspend a Drug Study Bristol-Myers executive charged with insider trading Bristol-Myers exec charged with insider trading |
Thursday, August 2, 2012
Bristol-Myers Insider Arrest Followed Probe of Deal - Bloomberg
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment